BioTech IQ
  • Home
  • Podcast
  • Hiring?
  • Blog
  • Contact
Select Page
Harnessing the Innate Immune System By Developing Three Types of iPSC-Derived Natural Killer Cells With Daniel Teper

Harnessing the Innate Immune System By Developing Three Types of iPSC-Derived Natural Killer Cells With Daniel Teper

by Ammon Rivera | Jul 15, 2022 | Podcast

  Companies in the biotech space are making contributions to help find a cure for cancer. Today’s guest is no exception. In today’s episode, Ammon Rivera sits down with Daniel Teper, Co-Founder and CEO of Cytovia Therapeutics, to talk about the unique technology...

Recent Posts

  • Qualigen Therapeutics: How Do You Develop A Successful Therapeutics Pipeline In Oncology With Amy Broidrick
  • Mapping The Human Immune System: Using AI To Change Drug Development With Noam Solomon
  • Going Beyond The Current Standard Of Care For Anxiety, Depression, And CNS Disorders With Shawn Singh
  • Harnessing the Innate Immune System By Developing Three Types of iPSC-Derived Natural Killer Cells With Daniel Teper
  • Cell Cycle Therapy: Understanding The Cell Cycle Biology To Treat Cancer With Spiro Rombotis

Recent Comments

  1. Ammon Rivera on Can Lineage Cell Therapeutics Proprietary Cell-Based Therapy Platform Change Treatment Development?
  2. Andy blidy on Can Lineage Cell Therapeutics Proprietary Cell-Based Therapy Platform Change Treatment Development?

Follow BioTech IQ 

  • Follow
  • Follow
  • Follow
biotech logo black

187 W Main St,
Suite 203
Lehi, UT 84043

Biotech IQ © Copyright 2022. All Rights Reserved